{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:35:20Z","timestamp":1778002520115,"version":"3.51.4"},"reference-count":73,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":139,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paolo Foundation"},{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Research Council","award":["341280 and 357481"],"award-info":[{"award-number":["341280 and 357481"]}]},{"name":"Finnish Cancer Organizations"},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helsinki University Hospital"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pathomechanisms that activate oncogenic B-cell receptor (BCR) signaling in diffuse large B-cell lymphoma (DLBCL) are largely unknown. Kelch-like family member 6 (KLHL6) encoding a substrate-adapter for Cullin-3-RING E3 ubiquitin ligase with poorly established targets is recurrently mutated in DLBCL. By applying high-throughput protein interactome screens and functional characterization, we discovered that KLHL6 regulates BCR by targeting its signaling subunits CD79A and CD79B. Loss of physiologic KLHL6 expression pattern was frequent among the MCD\/C5-like activated B-cell DLBCLs and was associated with higher CD79B levels and dismal outcome. Mutations in the bric-a-brac tramtrack broad domain of KLHL6 disrupted its localization and heterodimerization and increased surface BCR levels and signaling, whereas Kelch domain mutants had the opposite effect. Malfunctions of KLHL6 mutants extended beyond proximal BCR signaling with distinct phenotypes from KLHL6 silencing. Collectively, our findings uncover how recurrent mutations in KLHL6 alter BCR signaling and induce actionable phenotypic characteristics in DLBCL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Oncogenic BCR signaling sustains DLBCL cells. We discovered that Cullin-3-RING E3 ubiquitin ligase substrate-adapter KLHL6 targets BCR heterodimer (CD79A\/CD79B) for ubiquitin-mediated degradation. Recurrent somatic mutations in the KLHL6 gene cause corrupt BCR signaling by disrupting surface BCR homeostasis. Loss of KLHL6 expression and mutant-induced phenotypes associate with targetable disease characteristics in B-cell lymphoma.<\/jats:p>\n                    <jats:p>See related commentary by Leveille et al.<\/jats:p>\n                    <jats:p>See related commentary by Corcoran et al.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-23-0182","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T14:56:26Z","timestamp":1713365786000},"page":"331-352","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6378-5381","authenticated-orcid":false,"given":"Leo","family":"Meriranta","sequence":"first","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"},{"name":"Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. 2"},{"name":"iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4067-5536","authenticated-orcid":false,"given":"Selma","family":"Sorri","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"},{"name":"Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. 2"},{"name":"iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-670X","authenticated-orcid":false,"given":"Kanutte","family":"Huse","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. 4"},{"name":"KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-0536","authenticated-orcid":false,"given":"Xiaonan","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-8617","authenticated-orcid":false,"given":"Ivana","family":"Spasevska","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. 4"},{"name":"KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-1077","authenticated-orcid":false,"given":"Sadia","family":"Zafar","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-6951","authenticated-orcid":false,"given":"Iftekhar","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-0282","authenticated-orcid":false,"given":"Olli","family":"Dufva","sequence":"additional","affiliation":[{"name":"Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. 7"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1745-1468","authenticated-orcid":false,"given":"Eerika","family":"Sahlberg","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1431-2586","authenticated-orcid":false,"given":"Luka","family":"Tandari\u0107","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6728-2266","authenticated-orcid":false,"given":"Marja-Liisa","family":"Karjalainen-Lindsberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Helsinki University Hospital, Helsinki, Finland. 8"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3017-6862","authenticated-orcid":false,"given":"Marko","family":"Hyyti\u00e4inen","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-9732","authenticated-orcid":false,"given":"Markku","family":"Varjosalo","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0394-9986","authenticated-orcid":false,"given":"June H.","family":"Myklebust","sequence":"additional","affiliation":[{"name":"Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. 4"},{"name":"KG Jebsen Centre for B-cell malignancies and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-511X","authenticated-orcid":false,"given":"Sirpa","family":"Lepp\u00e4","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. 1"},{"name":"Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. 2"},{"name":"iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. 3"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2026041310180694600_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.18.02403","article-title":"Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non-germinal center B-cell diffuse large B-cell lymphoma","volume":"37","author":"Younes","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026041310180694600_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026041310180694600_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ni.1900","article-title":"Control systems and decision making for antibody production","volume":"11","author":"Goodnow","year":"2010","journal-title":"Nat Immunol"},{"key":"2026041310180694600_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ni1036","article-title":"B cell receptor signal strength determines B cell fate","volume":"5","author":"Casola","year":"2004","journal-title":"Nat Immunol"},{"key":"2026041310180694600_bib9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"2026041310180694600_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"2026041310180694600_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"2026041310180694600_bib12","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310180694600_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2016-10-747303","article-title":"Tonic B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"130","author":"Havranek","year":"2017","journal-title":"Blood"},{"key":"2026041310180694600_bib14","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.4049\/jimmunol.2200144","article-title":"Mechanism of CD79A and CD79B support for IgM+ B cell fitness through B cell receptor surface expression","volume":"209","author":"Huse","year":"2022","journal-title":"J Immunol"},{"key":"2026041310180694600_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"2026041310180694600_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"2026041310180694600_bib17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"2026041310180694600_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"2026041310180694600_bib19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"2026041310180694600_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"2026041310180694600_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0161-5890(03)00002-6","article-title":"Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells","volume":"39","author":"Gupta-Rossi","year":"2003","journal-title":"Mol Immunol"},{"key":"2026041310180694600_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ajcp\/aqx099","article-title":"KLHL6 is preferentially expressed in germinal center-derived B-cell lymphomas","volume":"148","author":"Kunder","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"2026041310180694600_bib23","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1128\/MCB.25.19.8531-8540.2005","article-title":"The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation","volume":"25","author":"Kroll","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2026041310180694600_bib24","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.4049\/jimmunol.1700708","article-title":"Klhl6 deficiency impairs transitional B cell survival and differentiation","volume":"199","author":"Bertocci","year":"2017","journal-title":"J Immunol"},{"key":"2026041310180694600_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"2026041310180694600_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"2026041310180694600_bib27","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310180694600_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"2026041310180694600_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"2026041310180694600_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"2026041310180694600_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"2026041310180694600_bib32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2020.01.029","article-title":"Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody","volume":"180","author":"Singh","year":"2020","journal-title":"Cell"},{"key":"2026041310180694600_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41556-018-0084-5","article-title":"Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2","volume":"20","author":"Choi","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2026041310180694600_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"2026041310180694600_bib35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","article-title":"The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma","volume":"39","author":"Steen","year":"2021","journal-title":"Cancer Cell"},{"key":"2026041310180694600_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"2026041310180694600_bib37","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"key":"2026041310180694600_bib38","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"2026041310180694600_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2014.05.039","article-title":"A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways","volume":"158","author":"Taipale","year":"2014","journal-title":"Cell"},{"key":"2026041310180694600_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2020.11.002","article-title":"Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas","volume":"54","author":"Dersh","year":"2021","journal-title":"Immunity"},{"key":"2026041310180694600_bib41","doi-asserted-by":"crossref","first-page":"eaap8236","DOI":"10.1126\/science.aap8236","article-title":"Dimerization quality control ensures neuronal development and survival","volume":"362","author":"Mena","year":"2018","journal-title":"Science"},{"key":"2026041310180694600_bib42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1091\/mbc.E15-12-0844","article-title":"An improved smaller biotin ligase for BioID proximity labeling","volume":"27","author":"Kim","year":"2016","journal-title":"Mol Biol Cell"},{"key":"2026041310180694600_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/emboj\/21.1.83","article-title":"BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor","volume":"21","author":"Yokoyama","year":"2002","journal-title":"EMBO J"},{"key":"2026041310180694600_bib44","doi-asserted-by":"crossref","first-page":"e201908132","DOI":"10.1083\/jcb.201908132","article-title":"LUZP1 and the tumor suppressor EPLIN modulate actin stability to restrict primary cilia formation","volume":"219","author":"Goncalves","year":"2020","journal-title":"J Cell Biol"},{"key":"2026041310180694600_bib45","doi-asserted-by":"crossref","first-page":"e55957","DOI":"10.7554\/eLife.55957","article-title":"LUZP1, a novel regulator of primary cilia and the actin cytoskeleton, is a contributing factor in Townes-Brocks Syndrome","volume":"9","author":"Bozal-Basterra","year":"2020","journal-title":"Elife"},{"key":"2026041310180694600_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.cr.7290047","article-title":"Activation-induced cell death in B lymphocytes","volume":"10","author":"Donjerkovic","year":"2000","journal-title":"Cell Res"},{"key":"2026041310180694600_bib47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41423-019-0254-9","article-title":"BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells","volume":"17","author":"Georg","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2026041310180694600_bib48","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12792","article-title":"Pathogenic B-cell receptor signaling in lymphoid malignancies: new insights to improve treatment","volume":"291","author":"Young","year":"2019","journal-title":"Immunol Rev"},{"key":"2026041310180694600_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2016-05-718494","article-title":"Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling","volume":"129","author":"Myklebust","year":"2017","journal-title":"Blood"},{"key":"2026041310180694600_bib51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMc2306105","article-title":"Cell-of-origin subtypes and therapeutic benefit from polatuzumab vedotin","volume":"389","author":"Palmer","year":"2023","journal-title":"N Engl J Med"},{"key":"2026041310180694600_bib52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00277-023-05161-1","article-title":"Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs","volume":"102","author":"Sheng","year":"2023","journal-title":"Ann Hematol"},{"key":"2026041310180694600_bib53","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"key":"2026041310180694600_bib54","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.1921187117","article-title":"Regulation of B cell receptor-dependent NF-\u03baB signaling by the tumor suppressor KLHL14","volume":"117","author":"Choi","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310180694600_bib55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-020-2636-7","article-title":"Structural basis for dimerization quality control","volume":"586","author":"Mena","year":"2020","journal-title":"Nature"},{"key":"2026041310180694600_bib56","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/bloodadvances.2020001727","article-title":"Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma","volume":"4","author":"Meriranta","year":"2020","journal-title":"Blood Adv"},{"key":"2026041310180694600_bib57","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/bloodadvances.2019001325","article-title":"Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series","volume":"4","author":"Wise","year":"2020","journal-title":"Blood Adv"},{"key":"2026041310180694600_bib58","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.3324\/haematol.2016.157495","article-title":"Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma","volume":"102","author":"Meriranta","year":"2017","journal-title":"Haematologica"},{"key":"2026041310180694600_bib59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2020.274258","article-title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","volume":"107","author":"Ma","year":"2022","journal-title":"Haematologica"},{"key":"2026041310180694600_bib60","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"key":"2026041310180694600_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41591-020-0757-z","article-title":"TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma","volume":"26","author":"Ennishi","year":"2020","journal-title":"Nat Med"},{"key":"2026041310180694600_bib62","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","article-title":"Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma","volume":"9","author":"Arthur","year":"2018","journal-title":"Nat Commun"},{"key":"2026041310180694600_bib63","doi-asserted-by":"crossref","first-page":"e20200483","DOI":"10.1084\/jem.20200483","article-title":"Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome","volume":"217","author":"Holmes","year":"2020","journal-title":"J Exp Med"},{"key":"2026041310180694600_bib64","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-16-2159","article-title":"Systematic in vivo inactivation of chromatin-regulating enzymes identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma","volume":"77","author":"Walter","year":"2017","journal-title":"Cancer Res"},{"key":"2026041310180694600_bib65","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin\u2019s lymphoma: distinctive tumor and microenvironment markers","volume":"22","author":"Nam-Cha","year":"2009","journal-title":"Mod Pathol"},{"key":"2026041310180694600_bib66","doi-asserted-by":"crossref","first-page":"15580","DOI":"10.1038\/s41598-017-15798-4","article-title":"Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis","volume":"7","author":"Blom","year":"2017","journal-title":"Sci Rep"},{"key":"2026041310180694600_bib67","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41596-020-0365-x","article-title":"Combined proximity labeling and affinity purification-mass spectrometry workflow for mapping and visualizing protein interaction networks","volume":"15","author":"Liu","year":"2020","journal-title":"Nat Protoc"},{"key":"2026041310180694600_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nmeth.1541","article-title":"SAINT: probabilistic scoring of affinity purification-mass spectrometry data","volume":"8","author":"Choi","year":"2011","journal-title":"Nat Methods"},{"key":"2026041310180694600_bib69","first-page":"8.15.1","article-title":"Analyzing protein-protein interactions from affinity purification-mass spectrometry data with SAINT","volume":"Chapter 8","author":"Choi","year":"2012","journal-title":"Curr Protoc Bioinformatics"},{"key":"2026041310180694600_bib70","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification-mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat Methods"},{"key":"2026041310180694600_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026041310180694600_bib72","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1073\/pnas.1002057107","article-title":"B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression","volume":"107","author":"Irish","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041310180694600_bib73","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0182\/3442880\/bcd-23-0182.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0182\/3483127\/bcd-23-0182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/5\/331\/3489949\/bcd-23-0182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/5\/331\/3489949\/bcd-23-0182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:18:32Z","timestamp":1776089912000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/5\/5\/331\/747358\/Disruption-of-KLHL6-Fuels-Oncogenic-Antigen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,17]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-23-0182","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.26926336.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926345.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926342.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926378.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926372","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926360","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926375.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926333.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926354","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926342","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926339.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926378","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926366","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926336","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926348","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926339","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926366.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926372.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926369.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926348.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926354.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926360.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926351","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926357.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926375","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926345","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926333","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926351.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926369","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.26926357","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7429450.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.7429450","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}